The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
National Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs
Abstract
CONTEXT: Although there are indications that antipsychotic drugs are increasingly used to treat children and adolescents, little is known about the characteristics of those who receive them. OBJECTIVE: To examine national trends and patterns in antipsychotic treatment of youth seen by physicians in office-based medical practice. DESIGN: Analysis of national trends of visits (1993-2002) that included prescription of antipsychotics, and comparison of the clinical and demographic characteristics of visits (2000-2002) that included or did not include antipsychotic treatment. SETTING: Outpatient visits to physicians in office-based practice. PARTICIPANTS: Patient visits by persons 20 years and younger from the National Ambulatory Medical Care Surveys from 1993 to 2002. MAIN OUTCOME MEASURES: Visits that included prescription of antipsychotics. RESULTS: In the United States, the estimated number of office-based visits by youth that included antipsychotic treatment increased from approximately 201,000 in 1993 to 1,224,000 in 2002. From 2000 to 2002, the number of visits that included antipsychotic treatment was significantly higher for male youth (1913 visits per 100,000 population) than for female youth (739 visits per 100,000 population), and for white non-Hispanic youth (1515 visits per 100,000 population) than for youth of other racial or ethnic groups (426 visits per 100,000 population). Overall, 9.2% of mental health visits and 18.3% of visits to psychiatrists included antipsychotic treatment. From 2000 to 2002, 92.3% of visits with prescription of an antipsychotic included a second-generation medication. Mental health visits with prescription of an antipsychotic included patients with diagnoses of disruptive behavior disorders (37.8%), mood disorders (31.8%), pervasive developmental disorders or mental retardation (17.3%), and psychotic disorders (14.2%). CONCLUSIONS: There has been a sharp national increase in antipsychotic treatment among children and adolescents in office-based medical practice. Second-generation antipsychotics are being widely prescribed, and emerging empirical evidence provides a base of support that is limited to short-term safety and efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Autistic Traits in the General Population: A Twin Study
Constantino, J. N., & Todd, R. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.524 · Cited by 1,317
SUDAAN User's Manual, Release 7.5,
Bieler, G. S., Barnwell, B., & Shah, B. V. (1997) · Cited by 1,273
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Calabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883
Correll, C. U., Leucht, S., & Kane, J. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.414 · Cited by 709
Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., Smith, I., & Dunbar, F. (2004) · Pediatrics · doi:10.1542/peds.2003-0264-f · Cited by 566
WOLRAICH, M. L., HANNAH, J. N., PINNOCK, T. Y., BAUMGAERTEL, A., & BROWN, J. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199603000-00013 · Cited by 546
Psychotropic Practice Patterns for Youth: A 10-Year Perspective
Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., Boles, M., Lynch, F., & Riddle, M. A. (2003) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.157.1.17 · Cited by 526
McDougle, C. J., Scahill, L., Aman, M. G., McCracken, J. T., Tierney, E., Davies, M., Arnold, L. E., Posey, D. J., Martin, A., Ghuman, J. K., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1142 · Cited by 482
Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & Risperidone Disruptive Behavior Study Group (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1337 · Cited by 475
DELBELLO, M. P., SCHWIERS, M. L., ROSENBERG, H. L., & STRAKOWSKI, S. M. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200210000-00011 · Cited by 443
National Trends in the Use of Psychotropic Medications by Children
OLFSON, M., MARCUS, S. C., WEISSMAN, M. M., & JENSEN, P. S. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200205000-00008 · Cited by 421
Self-citationChildhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
Kumra, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830120020005 · Cited by 410
A placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
Effects of Risperidone on Conduct and Disruptive Behavior Disorders in Children With Subaverage IQs
SNYDER, R., TURGAY, A., AMAN, M., BINDER, C., FISMAN, S., & CARROLL, A. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200209000-00002 · Cited by 335
Sikich, L., Hamer, R. M., Bashford, R. A., Sheitman, B. B., & Lieberman, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300327 · Cited by 308
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part II
PAPPADOPULOS, E., MACINTYRE, J. C., CRISMON, M. L., FINDLING, R. L., MALONE, R. P., DERIVAN, A., SCHOOLER, N., SIKICH, L., GREENHILL, L., SCHUR, S. B., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200302000-00008 · Cited by 289
Frazier, J. A., Biederman, J., Tohen, M., Feldman, P. D., Jacobs, T. G., Toma, V., Rater, M. A., Tarazi, R. A., Kim, G. S., Garfield, S. B., et al. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460152595568 · Cited by 247
Prevalence of tic disorders and Tourette syndrome in a Swedish school population
Khalifa, N., & von Knorring, A.-L. (2003) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162203000598 · Cited by 242
Risperidone Treatment for Juvenile Bipolar Disorder: A Retrospective Chart Review
FRAZIER, J. A., MEYER, M. C., BIEDERMAN, J., WOZNIAK, J., WILENS, T. E., SPENCER, T. J., KIM, G. S., & SHAPIRO, S. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199908000-00011 · Cited by 237
Risperidone in the Treatment of Tourette Syndrome: A Double-Blind, Placebo-Controlled Trial
Dion, Y., Annable, L., Sandor, P., & Chouinard, G. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00006 · Cited by 210
New Users of Antipsychotic Medications Among Children Enrolled in TennCare
Cooper, W. O., Hickson, G. B., Fuchs, C., Arbogast, P. G., & Ray, W. A. (2004) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.158.8.753 · Cited by 167
Autism and Autistic-like Conditions in Swedish Rural and Urban Areas: a Population Study
Steffenburg, S., & Gillberg, C. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.1.81 · Cited by 163
Stigler, K. A., Potenza, M. N., Posey, D. J., & McDougle, C. J. (2004) · Pediatric Drugs · doi:10.2165/00148581-200406010-00003 · Cited by 114
Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
Findling, R. L., & McNamara, N. (2004) · PubMed · Cited by 98
Pottick, K. J., McAlpine, D. D., & Andelman, R. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1267 · Cited by 94
Trends in Antipsychotic Use in a Texas Medicaid Population of Children and Adolescents: 1996 to 2000
Patel, N. C., Sanchez, R. J., Johnsrud, M. T., & Crismon, M. L. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386905 · Cited by 92
ZITO, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. L. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.2.157 · Cited by 83
Kaye, J. A., Bradbury, B. D., & Jick, H. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01905.x · Cited by 79
Risperidone in Children with Autism and Serious Behavioral Problems
Munarriz, R. M., Bennett, L., & Goldstein, I. (2002) · New England Journal of Medicine · doi:10.1056/nejm200212053472316 · Cited by 75
Toren, P., Ratner, S., Laor, N., & Weizman, A. (2004) · Drug Safety · doi:10.2165/00002018-200427140-00005 · Cited by 70
The Effect of Atypical Antipsychotic Agents on Prolactin Levels in Children and Adolescents
Pappagallo, M., & Silva, R. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.359 · Cited by 69
Prevalence of tic disorders among primary school students in the city of Pavia, Italy.
Lanzi, G., Zambrino, C. A., Termine, C., Palestra, M., Ginevra, O. F., Orcesi, S., Manfredi, P., & Beghi, E. (2004) · Europe PMC (PubMed Central) · Cited by 60
Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000
Martin, A., & LESLIE, D. L. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.10.997 · Cited by 50
Prevalence of Atypical Antipsychotic Drug Use Among Commercially Insured Youths in the United States
Curtis, L. H., Masselink, L. E., Østbye, T., Hutchison, S., Dans, P. E., Wright, A., Krishnan, R. R., & Schulman, K. A. (2005) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.159.4.362 · Cited by 49
Staller, J. A., Wade, M. J., & Baker, M. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.57 · Cited by 44
Patterns of mental health utilization and costs among children in a privately insured population.
LESLIE, D. L., Rosenheck, R. A., & Horwitz, S. M. (2001) · PubMed Central · Cited by 36
Regional Variation and Clinical Indicators of Antipsychotic Use in Residential Treatment
Rawal, P. H., Lyons, J. S., MacIntyre, J. C., & Hunter, J. C. (2004) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02287380 · Cited by 29
Blanco, C., Goodwin, R. D., Liebowitz, M. R., Schmidt, A. B., Lewis‐Fernández, R., & Olfson, M. (2004) · Medical Care · doi:10.1097/00005650-200412000-00011 · Cited by 12
Self-citation
Cited by
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
Ho, B.-C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.199 · Cited by 971
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1032 · Cited by 724
Self-citationTen Putative Contributors to the Obesity Epidemic
McAllister, E. J., Dhurandhar, N. V., Keith, S. W., Aronne, L. J., Barger, J., Baskin, M., Benca, R. M., Biggio, J., Boggiano, M. M., Eisenmann, J. C., et al. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903372599 · Cited by 710
Deacon, B. J. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.09.007 · Cited by 643
Metadata
- Authors
- Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2006-06-01
- Volume
- 63
- Issue
- 6
- Pages
- 679
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2150578657
- Cited by
- 591
- References
- 40
- FWCI
- 27.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.